Article
A novel polymorphism in the 17beta-hydroxysteroid dehydrogenase type 5 (aldo-keto reductase 1C3) gene is associated with lower serum testosterone levels in caucasian men.
The pharmacogenomics journal - 1 Aug 2007
Jakobsson J, Palonek E, Lorentzon M, Ohlsson C, Rane A, Ekström L
Abstract excerpt
Genetic variation in the androgen metabolizing enzymes is important to identify and feature as they may influence the risk of prostate cancer and help clarify the etiology of the disease. Human 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3) is highly expressed in the prostate gland and plays a major role in the formation and metabolism of androgens. We identified five novel polymorphisms in the AKR1C3 gene....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.